[1] |
SUN Rongqi, SONG Ning, ZHENG Wentian, ZHANG Xinyue, LI Minmin, GONG Hui, JIANG Yingying.
Effect of long noncoding RNA FLJ30679 on proliferation and migration of oral squamous cell carcinoma cells
[J]. China Oncology, 2024, 34(5): 439-450.
|
[2] |
XIONG Jiayan, LEI Wei, YOU Bo, ZHANG Zhenxin, XIE Haijing, SHAN Ying, XIA Tian, ZHOU Yong.
Study on the mechanism of DDX6 promoting proliferation and migration of nasopharyngeal carcinoma cells by regulating stability of CKMT1A mRNA
[J]. China Oncology, 2024, 34(5): 451-459.
|
[3] |
LIN Yicong, WANG Yue, XUE Qianqian, ZHENG Qiang, JIN Yan, HUANG Ziling, LI Yuan.
Clinical pathological characteristics and immune microenvironment significance of EGFR T790M mutation in non-small cell lung cancer patients and its prognostic implications
[J]. China Oncology, 2024, 34(4): 368-379.
|
[4] |
JIA Liqing, GE Xiaolu, JIANG Lin, ZHOU Xiaoyan.
Effects of lncRNA PKD2-2-3 on cell proliferation, clone formation, migration, and invasion of lung adenocarcinoma
[J]. China Oncology, 2023, 33(8): 717-725.
|
[5] |
ZHANG Lingling, WANG Xiangyi, WEI Xing, LIN Li, TANG Chuanhao, LIANG Jun.
A study on prevention and treatment of chemotherapy induced nausea and vomiting in non-small cell lung cancer patients with low-frequency electrical stimulator for antiemesis
[J]. China Oncology, 2023, 33(8): 776-781.
|
[6] |
SU Chunxia, ZHOU Caicun.
Important clinical research progress in lung cancer in 2022
[J]. China Oncology, 2023, 33(3): 218-227.
|
[7] |
HE Liyuan, WANG Yudong.
Research progress of ALK kinase domain drug resistance mutation and its future countermeasures
[J]. China Oncology, 2022, 32(8): 736-746.
|
[8] |
HONG Yaping, HUANG Yunjian, HUANG Zhangzhou, CHEN Shengjia, ZHONG Qiaofeng, ZENG Hongfu, ZHUANG Wu.
Efficacy and prognostic predictors of first-generation EGFR TKI-targeted therapy in patients with EGFR-mutated advanced non-small cell lung cancer
[J]. China Oncology, 2022, 32(7): 624-634.
|
[9] |
SU Chunxia, ZHOU Caicun.
Current status and future directions of immunotherapy for advanced non-small cell lung cancer
[J]. China Oncology, 2022, 32(6): 478-486.
|
[10] |
YU Silai, NI Jianjiao, ZHU Zhengfei.
Treatment of unresectable locally advanced non-small cell lung cancer in the era of immunotherapy: status and prospects
[J]. China Oncology, 2022, 32(6): 487-498.
|
[11] |
FU Yuanyuan, HOU Runping, FU Xiaolong.
Research progress in predicting the risk of lymphatic or hematologic metastasis based on chest CT in early non-small cell lung cancer
[J]. China Oncology, 2022, 32(4): 343-350.
|
[12] |
DUAN Yuqing, XIA Ning, JIA Yunlong, ZHENG Wenya, LIU Lihua.
SRSF1 promotes proliferation, invasion and migration of esophageal squamous cell carcinoma Eca9706 cells by regulating VEGFA mRNA alternative splicing
[J]. China Oncology, 2022, 32(3): 191-199.
|
[13] |
ZHU Haipeng, HU Jun, JIANG Min, CAI Ruonan, WANG Junqiao, LI Li.
A study on mechanism of GOLM1 regulating PI3K/AKT/mTOR signaling pathway to promote proliferation, invasion and migration of lung adenocarcinoma cells
[J]. China Oncology, 2022, 32(3): 207-217.
|
[14] |
ZHU Yihui, LI Ting, HU Xichun.
Clinical research progress and prospect of trastuzumab deruxtecan
[J]. China Oncology, 2021, 31(8): 754-761.
|
[15] |
LI Haizhou , ZHANG Yanwei , XU Yingjie , YANG Men , ZHANG Lei , HAN Jingjun .
miR-933 inhibits proliferation, migration and invasion of lung cancer cell lines by regulation of KLF6 gene
[J]. China Oncology, 2021, 31(7): 581-588.
|